Abstract:Modern lifestyle, changing eating habits and reduced physical work have been known to culminate into making diabetes a global pandemic. Hyperglycemia during the course of diabetes is an important causative factor for the development of both microvascular (retinopathy, nephropathy and neuropathy) and macrovascular (coronary artery disease, stroke and peripheral artery disease) complications. In this article, we summarize several mechanisms accountable for the development of both microvascular and macrovascular complications of diabetes. Several metabolic and cellular events are linked to the augmentation of oxidative stress like the activation of advanced glycation end products (AGE) pathway, polyol pathway, Protein Kinase C (PKC) pathway, Poly-ADP Ribose Polymerase (PARP) and hexosamine pathway. Oxidative stress also leads to the production of reactive oxygen species (ROS) like hydroxyl radical, superoxide anion and peroxides. Enhanced levels of ROS rescind the anti-oxidant defence mechanisms associated with superoxide dismutase, glutathione and ascorbic acid. Moreover, ROS triggers oxidative damages at the level of DNA, protein and lipids, which eventually cause cell necrosis or apoptosis. These physiological insults may be related to the microvascular complications of diabetes by negatively impacting the eyes, kidneys and the brain. While underlying pathomechanism of the macrovascular complications is quite complex, hyperglycemia associated atherosclerotic abnormalities like changes in the coagulation system, thrombin formation, fibrinolysis, platelet and endothelial function and vascular smooth muscle are well proven. Since hyperglycemia also modulates the vascular inflammation, cytokines, macrophage activation and gene expression of growth factors, elevated blood glucose level may play a central role in the development of macrovascular complications of diabetes. Taken collectively, chronic hyperglycemia and increased production of ROS are the miscreants for the development of microvascular and macrovascular complications of diabetes.

Clinical pathophysiology of diabetic microangiopathy

Review on Abnormal Apoptosis and Pathological Changes of Histiocyte Initiated by Diabetes Mellitus

[Cerebral Microangiopathy of Diabetes].

Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy

A Narrative Review of Diabetic Macroangiopathy: From Molecular Mechanism to Therapeutic Approaches

Molecular Mechanisms and Clinical Insights

A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications

MicroRNAs in diabetic macroangiopathy

CURRENT VIEW ON PATHOGENIC MECHANISMS OF DIABETIC RETINOPATHY

Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves

The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy

Pathogenesis of Diabetic Peripheral Neuropathy and Prospect of Antioxidative Therapy

A review regarding the article 'Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease: The Silesia Diabetes-Heart Project.'

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction

Cellular Senescence: A Bridge Between Diabetes and Microangiopathy

Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction

Associations Among Microvascular Dysfunction, Fatty Acid Metabolism, and Diabetes

Molecular mechanism and intervention measures of microvascular complications in diabetes

Involvement of mitochondrial dynamics and mitophagy in diabetic endothelial dysfunction and cardiac microvascular injury

Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases